Is Uber Stock a Buy on the Dip?
Shares of Uber Technologies (NYSE:UBER) have been fading fast in…
Buy
54
EDOC Quote, Financials, Valuation and Earnings
Last price:
$10.05
Seasonality move
:
-6.57%
Day range:
$9.81 - $10.15
52-week range:
$8.41 - $10.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
10.3K
Avg. volume:
22.6K
1-year change:
-1.08%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
$10.06 | -- | -- | -- | $0.00 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.48 | -- | -- | -- | $0.10 | 0.74% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$60.48 | -- | -- | -- | $0.00 | 0% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$9.84 | -- | -- | -- | $0.00 | 0% | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
$29.15 | -- | -- | -- | $0.00 | 0% | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
$25.73 | -- | -- | -- | $0.10 | 0.39% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | 1.935 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.009 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 1.316 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 2.318 | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | 1.788 | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | 1.113 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
HTEC
ROBO Global Healthcare Technology & Innovation ETF
|
-- | -- | -- | -- | -- | -- |
|
IBRN
iShares Neuroscience and Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
Global X Telemedicine & Digital Health ETF vs. Competitors
-
Which has Higher Returns EDOC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About EDOC or AGNG?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is EDOC or AGNG More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.927%.
-
Which is a Better Dividend Stock EDOC or AGNG?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.74% to investors and pays a quarterly dividend of $0.10 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or AGNG?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns EDOC or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About EDOC or BBP?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is EDOC or BBP More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.32%.
-
Which is a Better Dividend Stock EDOC or BBP?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or BBP?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns EDOC or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About EDOC or GNOM?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is EDOC or GNOM More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.125, suggesting its more volatile than the S&P 500 by 12.532%.
-
Which is a Better Dividend Stock EDOC or GNOM?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or GNOM?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
-
Which has Higher Returns EDOC or HTEC?
ROBO Global Healthcare Technology & Innovation ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat ROBO Global Healthcare Technology & Innovation ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- -
What do Analysts Say About EDOC or HTEC?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand ROBO Global Healthcare Technology & Innovation ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than ROBO Global Healthcare Technology & Innovation ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than ROBO Global Healthcare Technology & Innovation ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 HTECROBO Global Healthcare Technology & Innovation ETF0 0 0 -
Is EDOC or HTEC More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison ROBO Global Healthcare Technology & Innovation ETF has a beta of 1.070, suggesting its more volatile than the S&P 500 by 6.985%.
-
Which is a Better Dividend Stock EDOC or HTEC?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ROBO Global Healthcare Technology & Innovation ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. ROBO Global Healthcare Technology & Innovation ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or HTEC?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than ROBO Global Healthcare Technology & Innovation ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than ROBO Global Healthcare Technology & Innovation ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while ROBO Global Healthcare Technology & Innovation ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for ROBO Global Healthcare Technology & Innovation ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- HTECROBO Global Healthcare Technology & Innovation ETF-- -- -- --
-
Which has Higher Returns EDOC or IBRN?
iShares Neuroscience and Healthcare ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat iShares Neuroscience and Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- IBRNiShares Neuroscience and Healthcare ETF-- -- -- -
What do Analysts Say About EDOC or IBRN?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Neuroscience and Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than iShares Neuroscience and Healthcare ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than iShares Neuroscience and Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 IBRNiShares Neuroscience and Healthcare ETF0 0 0 -
Is EDOC or IBRN More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Neuroscience and Healthcare ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock EDOC or IBRN?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. iShares Neuroscience and Healthcare ETF offers a yield of 0.39% to investors and pays a quarterly dividend of $0.10 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. iShares Neuroscience and Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or IBRN?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than iShares Neuroscience and Healthcare ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than iShares Neuroscience and Healthcare ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while iShares Neuroscience and Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for iShares Neuroscience and Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- IBRNiShares Neuroscience and Healthcare ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
LMND alert for Dec 28
Lemonade [LMND] is down 10.69% over the past day.
Sell
50
TSLL alert for Dec 28
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 9.92% over the past day.
Buy
63
SMLR alert for Dec 28
Semler Scientific [SMLR] is down 9.65% over the past day.
